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BACKGROUND:When a biologic mechanism of interest is anticipated to operate differentially according to sex, as is often the case in endocrine disrup-
tors research, investigators routinely estimate sex-specific associations. Less attention has been given to potential sexual heterogeneity of confounder
associations with outcomes. When relationships of covariates with outcomes differ according to sex, commonly applied statistical approaches for esti-
mating sex-specific endocrine disruptor effects may produce divergent estimates.
OBJECTIVES:We discuss underlying assumptions and evaluate the performance of two traditional approaches for estimating sex-specific effects, strati-
fication and product terms, and introduce a simple modeling alternative: an augmented product term approach.
METHODS:We describe the impact of assumptions regarding sexual heterogeneity of confounder relationships on estimates of sex-specific effects of
the exposure of interest for three approaches: stratification, traditional product terms, and augmented product terms. Using simulated and applied
examples, we demonstrate properties of each approach under a range of scenarios.
RESULTS: In simulations, sex-specific exposure effects estimated using the traditional product term approach were biased when confounders had sex-
dependent associations with the outcome. Sex-specific estimates from stratification and the augmented product term approach were unbiased but less
precise. In the applied example, the three approaches yielded similar estimates, but resulted in some meaningful differences in conclusions based on
statistical significance.
CONCLUSIONS: Investigators should consider sexual heterogeneity of confounder associations when choosing an analytic approach to estimate sex-
specific effects of endocrine disruptors on health. In the presence of sex-dependent confounding, our augmented product term approach may be advan-
tageous over stratification when there is prior knowledge available to fit reduced models or when investigators seek an automated test for effect mea-
sure modification. https://doi.org/10.1289/EHP334
Introduction
Research on health effects of endocrine-disrupting chemicals
(EDs) has increased rapidly in the last decade. This work is predi-
cated on the principle that chemicals that interact with the endo-
crine system may affect health outcomes that are regulated by that
system (Colborn et al. 1993). When an ED is thought to interfere
with the synthesis, activity, or elimination of sex hormones or
other hormones involved in sexually dimorphic biologic processes
(e.g., thyroid), researchers routinely employ statistical methods to
assess whether the relationship between the ED and health out-
come differs by the sex of the individual. This practice is logical
for endpoints that are influenced by hormones and is particularly
relevant for studies of developmental outcomes with well-
described sexually dimorphic trajectories (Ingleby et al. 2014;
Lenroot et al. 2007; Ronen and Benvenisty 2014). For example,
sexual dimorphism in human brain anatomy (Lenroot et al. 2007)
and epigenetic processes (Nugent and McCarthy 2011) have been
proposed as potential explanations for sex-related differences in
behavior and risk of developmental disabilities.
Although sexual heterogeneity of associations between EDs
and outcomes is often of major interest, sexual heterogeneity of
covariate–outcome relationships is less often scrutinized. And
yet, many commonly considered confounders in ED studies may
themselves have sex-specific effects. In studies of EDs and child
neurodevelopment, for example, instruments that evaluate parent-
ing and the home environment are often included as confounders.
Although parenting styles have been reported to have sex-
specific associations with behavior, conduct problems, and lan-
guage development (Braza et al. 2015; Tung et al. 2012;
Vallotton et al. 2012), the potential for sex differences in con-
founding by these instruments is typically overlooked. We sug-
gest that common modeling approaches for estimating sex-
specific effects of EDs may not yield equivalent estimates due to
the presence of such sex-dependent confounding.
We review strategies for estimating sex-specific effects (i.e.,
stratification and product term models) and propose a simple
modeling alternative: an augmented product term approach.
Using causal diagrams and a simulation study, we elucidate
underlying assumptions about covariate–outcome relationships
implied by each approach and discuss performance of these
methods in terms of bias, precision, mean squared error (MSE),
confidence interval coverage, power, and heterogeneity testing.
Finally, we describe a motivating example from our own previ-
ous research in which estimates generated using these approaches
yielded some meaningful differences in conclusions.
Description of the Problem
Two approaches are commonly applied to estimate sex-specific
effects of exposures on outcomes: stratification and product term
models. We define stratification as estimation of exposure–out-
come associations separately in datasets comprised only of either
males or females. We define product term models as estimation
of exposure–outcome associations in a single dataset using an ex-
posure by sex product term. To illustrate assumptions underlying
these approaches, we consider a scenario in which we are inter-
ested in assessing relationships between a continuously measured
exposure (X), a binary confounder (Z), a binary indicator of sex
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(S), and a continuous outcome of interest (Y). Figure 1A is a
causal diagram representing one potential set of causal associa-
tions between these variables.
Under the causal diagram in Figure 1A, adjustment for Z is
sufficient to estimate an unconfounded association between X and
Y. However, a well-known limitation of causal diagrams is that
effect measure modification (EMM) on the model scale is not
easily represented (Weinberg 2007). The inability to depict heter-
ogeneity on a single causal diagram may, in part, contribute to
under-recognition of the problem of interest in this commentary.
One way to express information on sex differences is to draw sep-
arate causal diagrams for males and females. Further, the use of
signed causal diagrams allows us to represent differential effects
by sex (VanderWeele and Robins 2010).
In Figures 1B and 1C, we use signed causal diagrams to dem-
onstrate a reason for our central concern: the direction or magni-
tude of confounding may depend on S. Both causal diagrams
assume no heterogeneity by S of the association between Z and
X. However, we encode prior knowledge that the association
between Z and Y differs among strata of S. For illustrative pur-
poses, we specify a situation with opposing directions of associa-
tion, although we could have specified a difference in magnitudes
of a same-direction effect or no effect in one stratum of S. As
shown in the diagrams of Figure 1, associations between Z and Y
differ depending on the value of S. Such heterogeneity can poten-
tially guide model fitting when evaluating associations between
exposure and outcome, and may also affect how we should inter-
pret estimates of heterogeneity within such models.
We describe three potential regression models for estimating
the sex-specific effects of X with Y, controlling for Z (Table 1).
As described above, the two most commonly applied methods
are stratification and the use of an exposure by sex product term
(traditional product term approach). The stratification approach is
to fit separate models for the effect of X on Y in datasets stratified
by levels of S. The traditional product term approach uses a prod-
uct term between X and S to allow the effect of X on Y to differ
by S.
In stratification, beta coefficients for both X and Z are esti-
mated separately in datasets subset by strata of S. This allows not
only the X ! Y association to differ by sex, but also the Z ! Y
association to differ by sex. In contrast, the traditional product
term approach estimates the beta coefficient for Z without respect
to S, representing a weighted average of the sex-specific effects
of Z on Y. If the Z ! Y association differs by sex, as in our
Figures 1B and 1C, the traditional product term approach does
not fully control for confounding by Z. However, this approach is
often preferred over stratification because one may easily conduct
a test of heterogeneity for the X ! Y association by S (e.g., a
Wald test or likelihood ratio test comparing models with and
without the X by S product term). Heterogeneity testing using the
stratification approach is less common, but can be achieved with
a two-sample z-test using model-estimated beta coefficients and
variances (Paternoster et al. 1998).
We propose an augmented product term approach as an alter-
native to these methods. Here, we include a Z by S product term
in addition to the X by S product term. The sex-specific exposure
effects (the beta coefficients for X and the X by S product term)
are now adjusted for sex-specific effects of Z. In the simple sce-
nario represented by Figures 1B and 1C, stratification and the
augmented product term approach yield identical parameter esti-
mates, but the latter approach allows the investigator to formally
examine heterogeneity of the X ! Y association by S (e.g., using
a Wald test or likelihood ratio test for the X by S product term).
Simulation Example
Methods
We sought to illustrate differences in approaches using a simple
but realistic simulation scenario. For this example, we simulated
data from a hypothetical study assessing sex-specific associations
of a log-normally distributed continuous exposure with a nor-
mally distributed continuous outcome in a sample size of 250, a
common scenario and representative sample size for studies of
ED research among children. We modeled exposure based on the
distribution of third trimester maternal urinary mono-n-butyl
phthalate (MnBP) concentrations observed in the Mount Sinai
Children’s Environmental Health Center Study. We modeled the
outcome after the Mental Development Index (MDI), an age- and
sex-standardized neurodevelopmental scale. We included an
unspecified binary covariate, Z1, to represent a confounder with
sexually heterogeneous effects on MDI (such as parenting style),
and included an additional binary covariate, Z2, in some
scenarios.
For the primary simulated data scenario, we specified random
variables as described in Table 2. Boys are denoted by S=0 and
girls by S=1. The outcome was, on average, two units higher
among girls (bS =2Þ. We specified modification of the associa-
tion between X and Y on the additive scale, such that exposure
had no effect in boys [bXðS=0Þ =0], and each one-unit increase in
natural log MnBP exposure reduced mean MDI scores by two
points in girls [bXðS=1Þ = − 2]. We also specified strong additive
modification of the association between Z1 and Y such that Z1
was unassociated with MDI scores in boys [bZ1ðS=0Þ =0], but
was related to higher scores in girls [bZ1ðS=1Þ =5].
We note that in the scenario described by this causal diagram,
sex does not affect the exposure or confounder (i.e., no arrow
between S and X or between S and Z1. This is often a reasonable
assumption, particularly in studies estimating effects of prenatal
exposures, but the foundations of our argument apply to scenar-
ios when S may also be a confounder. We ran additional simula-
tions under the following alternative scenarios: Scenario 2:
negative (rather than positive) Z1 ! Y association in girls
[bZ1ðS=1Þ = − 5]; Scenario 3: no modification by sex of Z1 ! Y
association [bZ1ðS=0Þ = bZ1ðS=1Þ =5]; Scenario 4: sex not asso-
ciated with Y (bS =0Þ; Scenario 5: weaker modification by sex
of Z1 ! Y association [bZ1ðS=0Þ =0; bZ1ðS=1Þ =2]; Scenario 6:
Figure 1. Causal diagrams for relationships between exposure (X), out-
come (Y), a measured covariate (Z), and sex (S) in the overall population
(A), for S=0 (B), and for S=1 (C).
Table 1. Approaches for estimating sex-specific associations.
Approach Linear regression equation
1. Stratification: Y =a+ b1X +b2Z; where S=0
Stratify by sex Y =a+ b1X +b2Z; where S=1
2. Traditional product term:
Y =a+b1X+ b2S+b3XS+b4ZExposure by sex product
term
3. Augmented product term:
Y =a+ b1X +b2S+b3XS+b4Z +b5ZSExposure by sex product
term and confounder by
sex product term
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additional confounder with sex-specific associations with Y
[bZ2ðS=0Þ = − 5; bZ2ðS=1Þ =0]; Scenario 7: additional con-
founder with sex-specific associations with Y [bZ2ðS=0Þ =0;
bZ2ðS=1Þ = − 5]; and Scenario 8: additional confounder with-
out sex-specific associations with Y [bZ2ðS=0Þ = bZ2ðS=1Þ =
− 5].
We estimated associations between exposure and outcome
using linear regression models fit with each of the three analysis
methods detailed in Table 1. We also tested a reduced version of
the augmented product term approach for Scenario 8, where the
model included a sex product term for Z1 but not Z2. We report
average beta coefficients, standard errors, and MSE (squared bias
plus variance) across 10,000 simulated datasets. We calculated
confidence interval coverage as the percent of simulations in which
the 95% confidence interval included the true coefficient value.We
calculated power for effect estimates as the percent of simulations
in which the 95% confidence intervals excluded the null hypothesis
(for the null effect in boys, this is equivalent to the type I error rate).
We also report the power to assess heterogeneity as the percent of
simulations that identified statistically significant EMM(two-sided
alpha of 0.1). For stratified models, we tested EMM using a two-
sample z-test to compare the coefficients for boys and girls, with
the test statistic given as Z = ½bX S=0ð Þ − bX S=1ð Þ½Var bX S=0ð Þ
 
+
Var bX S=1ð Þ
 -one-half (Paternoster et al. 1998), where model esti-
mates of the coefficients and variances were used to calculate
the statistics. For the traditional and augmented product term
approaches, we determined power using model-based Wald
p-values, which are output by default in SAS. As a sensitivity
analysis to examine performance of the approaches in a larger
sample size, all analyses were repeated using N=500. We con-
ducted analyses using SAS version 9.4 and fit linear regression
models using the GENMOD procedure (SAS Institute Inc.).
Simulation code is available in Supplemental Material, Simulation
Code.
Results
Simulation results are presented in Table 3. All results for stratifi-
cation and the augmented product term approach were identical.
In all scenarios, stratification and the augmented product term
approach yielded unbiased exposure–outcome effect estimates
for both boys and girls. The traditional product term approach
yielded biased results except when there was no sex-dependent
confounding (Scenario 3) or when two sex-dependent confound-
ers had equal and opposite associations with the outcome, and
bias was effectively canceled out (Scenario 6). In the primary sce-
nario, the exposure coefficient estimated with the traditional
product term approach was biased down and away from the null
for boys (bias= − 0:4) and up and toward the null for girls
(bias= 0:4).
Standard errors were consistently smaller for the traditional
product term approach than they were for stratification or the
augmented product term approach. MSEs were also slightly
smaller for the traditional product term approach except in
Scenario 6, where coefficients estimated with this approach had
large bias. When the sample size was increased to 500, which
resulted in smaller standard errors for all approaches, stratifica-
tion and the augmented product term approach had smaller MSE
than the traditional approach in Scenarios 1, 2, 4, and 6 (see
Table S1).
For main effects, 95% confidence intervals estimated using
stratification and augmented product terms contained the true
value in 94% to 95% of simulations for all approaches. The 95%
confidence interval coverage using the traditional product term
approach ranged between 90% and 95% in the main analyses
(Table 3), and between 86% and 95% when the sample size was
increased to 500 (see Table S1). The type I error rate for the null
effect in boys (expressed as power) followed a similar pattern to
the coverage statistic and was 5% to 6% for all scenarios at both
sample sizes when using stratification or augmented product
terms. The traditional product term approach had type I error
rates >5% in all scenarios where this approach yielded biased
estimates; the type I error rate was highest when estimates were
both biased and precise, ranging up to 14% in Scenario 7 with
N =500.
Compared with stratification and the augmented product term
approach, the traditional product term approach had lower power
to detect the main effect in girls and effect measure modification
in all five scenarios where sex-dependent confounding caused
coefficients estimated using this approach to be biased toward the
null (Scenarios 1, 4, 5, 7, and 8). In Scenario 3 (no sex-dependent
confounding) and Scenario 6 (two sex-dependent confounders
with equal and opposite associations with the outcome), the tradi-
tional product term approach had slightly better power because
estimates were unbiased and standard errors were smaller than
the other two approaches. In Scenario 2, the traditional product
term model exhibited greater power than the other approaches,
due in part to smaller standard errors, but also to substantial bias
away from the null, which increased the number of simulations
detecting a statistically significant association.
In Scenario 8, where Z1 had sex-dependent effects but Z2 did
not, a reduced version of the augmented product term approach
performed well. Estimates were unbiased, had 94% to 95% confi-
dence interval coverage, and the average standard errors for
boys and girls were both 1.08. The average MSE was 2.37 for
boys and 2.39 for girls, which was higher than the traditional,
but lower than the full augmented product term approach. The
reduced model had the expected 5% type I error rate for the null
effect in boys and greater power than the other approaches to
detect the main effect in girls (46%) and EMM (39%).
Applied Example
The present study was motivated by our previous experiences
estimating sex-specific effects of endocrine-disrupting com-
pounds in the Mount Sinai Children’s Environmental Health
Center study. To illustrate the impact of different approaches in
real data, we reanalyzed results of a previous study of prenatal
Table 2. Simulation study parameters.
Parameter specification Variable description
S ∼ Bernoullið0:5Þ Child’s sex (50% girls)
Z ∼ Bernoullið0:5Þ Binary covariate (50% prevalence)
X ∼ Normalð3+Z,1:2Þ Continuous normally distributed log-transformed exposure dependent on Z,
modeled after mono-n-butyl phthalate (mean= 3:5, SD=1:2)
Y ∼ Normal ½ 101:75+ ðbX S=0ð Þ  XÞ+ ðbX S=1ð Þ  X  SÞ+ ð2  SÞ+

ð5  Z  SÞÞ, 15
Continuous normally distributed outcome, modeled after the Mental
Development Index (mean= 100, SD=15)
Note: SD, standard deviation.
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phthalate metabolite concentrations and child neurodevelopment
(Doherty et al. 2017).
Methods
Details of the Mount Sinai Children’s Environmental Health
Center study have been described previously (Engel et al. 2007).
Briefly, primiparous women with singleton pregnancies were en-
rolled at the Mount Sinai Diagnostic and Treatment Center and
two private practices in New York City, and delivered at Mount
Sinai Medical Center between 1998 and 2001. In the third trimes-
ter, women completed an interviewer-administered questionnaire
and provided a spot urine sample. Birth data were obtained from
a computerized perinatal database. The pregnancy cohort in-
cludes 404 mother–infant pairs. Using procedures described pre-
viously (Kato et al. 2005), prenatal urine samples were analyzed
at the Centers for Disease Control and Prevention (CDC) for the
following phthalate metabolites: monoethyl phthalate (MEP),
mono-n-butyl phthalate (MnBP), mono-isobutyl phthalate (MiBP),
mono(3-carboxypropyl) phthalate (MCPP), monobenzyl phthalate
(MBzP), mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-
hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl)
phthalate (MEOHP), and mono(2-ethyl-5-carboxypentyl) phthalate
(MECPP). The four metabolites of di(2-ethylhexyl) phthalate




As described by Doherty et al. (2017), 276 children who
attended a follow-up visit at 24 months of age were administered
the Bayley Scales of Infant Development II, which produces two
indices of cognitive and psychomotor development: the MDI and
the Psychomotor Development Index (PDI). Age- and sex-
standardized scores for the MDI and PDI have a mean of 100
(range: 50 to 150) and a standard deviation of 15 (Bayley 1993).
Women provided informed consent prior to participation, and
the study received approval from the Mount Sinai School of
Medicine Institutional Review Board. The involvement of the
CDC laboratory was determined not to constitute engagement in
research of human subjects. The current analysis was approved
by University of North Carolina at Chapel Hill Office of Human
Research Ethics.
This analysis builds on the work of Doherty et al. (2017) to
illustrate the use of stratification, traditional product term, and
augmented product term approaches to estimate sex-specific
effects. The analysis includes 258 children with measured prena-
tal phthalate metabolite concentrations and valid MDI/PDI
scores. We followed the analysis strategy of the previous study to
estimate sex-specific associations of each phthalate metabolite or
DEHP sum with child MDI and PDI (Doherty et al. 2017).
Briefly,we creatinine-standardized natural log phthalate biomarker
concentrations as recommended by O’Brien et al. (O'Brien et al.
2016), and estimated associations in linear regression models
adjusted for natural log–transformed creatinine (mg/dL),
Table 3. Simulation results implementing three approaches to estimate sex-specific effects of X on Y (N =250).
Scenario/parameter
Stratificationa Traditional product termb Augmented product termc
b SE MSE Coverage Power b SE MSE Coverage Power b SE MSE Coverage Power
Scenario 1
bðboysÞ 0.0 1.12 2.56 95% 5% −0:4 1.08 2.51 93% 7% 0.0 1.12 2.56 95% 5%
bðgirlsÞ −2:0 1.12 2.57 94% 44% −1:6 1.08 2.53 93% 33% −2:0 1.12 2.57 94% 43%
EMM 36% 23% 36%
Scenario 2
bðboysÞ 0.0 1.12 2.56 95% 5% 0.4 1.08 2.52 94% 6% 0.0 1.12 2.56 95% 5%
bðgirlsÞ −2:0 1.12 2.57 94% 44% −2:4 1.08 2.53 93% 59% −2:0 1.12 2.57 94% 43%
EMM 36% 59% 36%
Scenario 3
bðboysÞ 0.0 1.12 2.56 95% 5% 0.0 1.08 2.36 95% 5% 0.0 1.12 2.56 95% 5%
bðgirlsÞ −2:0 1.12 2.57 94% 44% −2:0 1.08 2.37 95% 46% −2:0 1.12 2.57 94% 43%
EMM 36% 40% 36%
Scenario 4
bðboysÞ 0.0 1.12 2.56 95% 5% −0:4 1.08 2.51 93% 7% 0.0 1.12 2.56 95% 5%
bðgirlsÞ −2:0 1.12 2.57 94% 44% −1:6 1.08 2.53 93% 33% −2:0 1.12 2.57 94% 43%
EMM 36% 23% 36%
Scenario 5
bðboysÞ 0.0 1.12 2.56 95% 5% −0:1 1.08 2.39 95% 5% 0.0 1.12 2.56 95% 5%
bðgirlsÞ −2:0 1.12 2.57 94% 44% −1:9 1.08 2.40 94% 41% −2:0 1.12 2.57 94% 43%
EMM 36% 32% 36%
Scenario 6
bðboysÞ 0.0 1.12 2.58 94% 6% 0.0 1.05 2.25 95% 5% 0.0 1.12 2.58 95% 6%
bðgirlsÞ −2:0 1.12 2.58 95% 43% −2:0 1.05 2.26 95% 47% −2:0 1.12 2.58 95% 43%
EMM 35% 42% 35%
Scenario 7
bðboysÞ 0.0 1.12 2.58 94% 6% −0:7 1.05 2.69 90% 10% 0.0 1.12 2.58 95% 6%
bðgirlsÞ −2:0 1.12 2.58 95% 43% −1:3 1.05 2.69 90% 25% −2:0 1.12 2.58 95% 43%
EMM 35% 14% 35%
Scenario 8
bðboysÞ 0.0 1.12 2.58 94% 6% −0:3 1.05 2.35 93% 7% 0.0 1.12 2.58 95% 6%
bðgirlsÞ −2:0 1.12 2.58 95% 43% −1:7 1.05 2.35 93% 36% −2:0 1.12 2.58 95% 43%
EMM 35% 26% 35%
Notes: EMM, effect measure modification; MSE, mean squared error; SE, standard error; bðboysÞ=0 and bðgirlsÞ= − 2. Scenario 1: Primary results. Scenario 2: Negative (rather
than positive) Z1 ! Y association in girls (bZ1ðS=1Þ = − 5Þ Scenario 3: No modification by sex of Z1 ! Y association (bZ1ðS=0Þ =bZ1ðS=1Þ =5Þ Scenario 4: Sex not associated with Y
(bS =0Þ. Scenario 5: Weaker modification by sex of Z1 ! Y association (bZ1ðS=0Þ =0; bZ1ðS=1Þ =2Þ Scenario 6: Additional confounder with sex-specific associations with Y
(bZ2ðS=0Þ = − 5; bZ2ðS=1Þ =0Þ. Scenario 7: Additional confounder with sex-specific associations with Y (bZ2ðS=0Þ =0; bZ2ðS=1Þ = − 5Þ. Scenario 8: Additional confounder without sex-
specific associations with Y (bZ2ðS=0Þ =bZ2ðS=1Þ = − 5Þ.
aStratify by sex.
bExposure by sex product term.
cExposure by sex product term and covariate by sex product term.
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prepregnancy body mass index (kg=m2), maternal race/ethnicity
(Hispanic/White/Black/other), maternal education (less than high
school/high school graduate/some college/college graduate),
Home Observation for Measurement of the Environment (HOME)
score (Caldwell and Bradley 1979), duration of breastfeeding in
months, maternal age in years, child age at testing in months, and
maternal marital status (single/married/living with father). Child’s
sexwas evaluated inmodels as an effectmeasuremodifier.
For the stratification approach, we estimated exposure associ-
ations in separate datasets for boys and girls. For the traditional
product term approach, we included sex as a covariate and esti-
mated exposure associations by including an exposure by sex
product term. For the augmented product term approach, we
included sex as a covariate, estimated exposure associations by
including an exposure by sex product term, and also included
product terms between sex and all adjustment variables. We also
fit models using a reduced version of the augmented product term
approach. For these models, we did not include product terms
between sex and three variables: natural log creatinine, maternal
age, and maternal body mass index. We selected product terms to
remove for this post hoc analysis based on our prior expectation
that these variables would not have sex-dependent effects on neu-
rodevelopment, which we confirmed by examining associations
in our data.
For the stratification approach, we calculated the p-value for
EMM by child’s sex using model-based beta coefficients and
standard errors, as above. For the product term approaches, we
report the model-based Wald p-value. We considered modifica-
tion to be statistically significant at an alpha level of 0.1. We fit
linear regression models using the GENMOD procedure in SAS
version 4.0 (SAS Institute Inc.).
Results
Estimated sex-specific associations of phthalate biomarkers with
MDI scores are reported in Table 4. Beta coefficients from the
stratified approach are identical to those from the augmented
product term approach. In both sexes, precision differed between
these two approaches because the stratified approach allows the
variance of the error term to differ by sex, whereas the augmented
product term approach does not. We note that standard errors
from the two approaches will not differ in expectation when the
residual variance in the outcome is similar in both groups (as
demonstrated in the simulation).
Estimates from the traditional product term approach had the
smallest standard errors, and beta coefficients were generally far-
ther from the null for boys and closer to the null for girls than
estimates from other approaches. Using the stratified approach,
three of the six phthalate biomarkers were significantly associated
with lower MDI scores among girls, whereas there were no statis-
tically significant associations among girls using the traditional
product term approach (Table 4). The augmented and reduced
augmented product term approaches yielded statistically signifi-
cant associations for two and one phthalate biomarkers, respec-
tively, but beta coefficients were more comparable to the
stratified model than were the beta coefficients from the tradi-
tional product term model.
Conclusions regarding EMM did not differ by approach at our
a priori alpha level of 0.1. Small differences between the EMM
p-values reported for stratification and the augmented product
term approach were due to rounding error in the hand calculation
for stratification. We observed similar patterns for the PDI,
though differences in beta coefficients were smaller, and all
approaches led to the same conclusions based on statistical tests
(see Table S2).
In our data, we believe the differences in parameter estimates
are driven by residual confounding by sex-dependent associations
of the covariates with child neurodevelopment. We observed het-
erogeneity of associations between maternal race/ethnicity,
maternal education, and HOME score with MDI score by child’s
sex. For example, higher levels of maternal education were
strongly associated with higher MDI scores in girls but not boys
(EMM p-value<0:05 for girls in each of the two highest educa-
tion levels compared to boys). Sex differences in associations of
these variables with MDI may be related to parenting styles,
which have been associated with sex differences in child neurode-
velopment (Braza et al. 2015; Tung et al. 2012; Vallotton et al.
2012) or other factors that are currently understudied. This differ-
ence in confounding by sex is unspecified in the traditional prod-
uct term approach, which likely leads to bias of stratum-specific
estimates.
Discussion
Our findings provide guidance to investigators who observe dif-
ferent results when fitting stratified and traditional product term
models. In our experience, investigators intuitively expect the
two approaches to yield similar findings and may not fully appre-
ciate the cause of any differences in results. Our analyses suggest
Table 4. Change in Mental Development Index score per unit change in ln-
transformed standardized phthalate metabolite concentration in boys and girls.
Approach/metabolite
Boys (n=131) Girls (n=116) EMM
p-valueb (SE) 95% CI b (SE) 95% CI
Stratificationa
MEP 1.0 (0.7) −0:5, 2:4 −0:1 ð0:8Þ −1:7, 1:5 0.3
MnBP 1.7 (0.8) 0.1, 3.3 −2:8 ð1:1Þ −5:0,− 0:5 0.001
MiBP 1.5 (1.0) −0:4, 3:5 −2:3 ð1:0Þ −4:3,− 0:2 0.008
MCPP 2.0 (1.0) 0.0, 4.1 −2:4 ð1:2Þ −4:7, 0:0 0.005
MBzP 1.8 (0.9) 0.1, 3.6 −0:6 ð0:9Þ −2:3, 1:1 0.05P
DEHP 0.1 (0.8) −1:5, 1:7 1.8 (1.0) −0:1, 3:7 0.2
Traditionalb
MEP 1.1 (0.7) −0:2, 2:4 −0:4 ð0:8Þ −2:1, 1:2 0.1
MnBP 1.9 (0.8) 0.3, 3.4 −2:2 ð1:2Þ −4:6, 0:1 0.004
MiBP 1.6 (0.9) −0:2, 3:4 −2:0 ð1:1Þ −4:1, 0:2 0.009
MCPP 1.8 (1.0) −0:2, 3:7 −2:0 ð1:3Þ −4:5, 0:5 0.02
MBzP 1.8 (0.8) 0.2, 3.4 −0:6 ð0:9Þ −2:3, 1:1 0.03P
DEHP 0.3 (0.8) −1:2, 1:8 1.2 (1.0) −0:7, 3:2 0.5
Augmentedc
MEP 1.0 (0.7) −0:4, 2:3 −0:1 ð0:9Þ −1:8, 1:6 0.3
MnBP 1.7 (0.8) 0.2, 3.2 −2:8 ð1:2Þ −5:2,− 0:3 0.002
MiBP 1.5 (0.9) −0:3, 3:4 −2:3 ð1:1Þ −4:5, 0:0 0.009
MCPP 2.0 (1.0) 0.1, 4.0 −2:4 ð1:3Þ −4:9, 0:2 0.007
MBzP 1.8 (0.8) 0.2, 3.5 −0:6 ð0:9Þ −2:4, 1:2 0.05P
DEHP 0.1 (0.8) −1:4, 1:6 1.8 (1.1) −0:3, 3:9 0.2
Reduced augmentedd
MEP 1.0 (0.7) −0:4, 2:3 −0:1 ð0:8Þ −1:8, 1:6 0.3
MnBP 1.7 (0.8) 0.2, 3.2 −2:7 ð1:2Þ −5:1,− 0:3 0.002
MiBP 1.5 (0.9) −0:3, 3:3 −2:1 ð1:1Þ −4:3, 0:1 0.01
MCPP 2.0 (1.0) 0.1, 3.9 −2:2 ð1:2Þ −4:6, 0:2 0.007
MBzP 1.8 (0.8) 0.2, 3.4 −0:5 ð0:9Þ −2:3, 1:3 0.06P
DEHP 0.2 (0.7) −1:3, 1:6 1.4 (1.0) −0:5, 3:3 0.3
Notes: CI, confidence interval; EMM, effect measure modification; SE, standard error;
Beta coefficient (SE) and 95% CI per natural log increase in creatinine-standardized
phthalate biomarker concentrations estimated in linear regression models adjusted for
ln-transformed urinary creatinine concentration, prepregnancy body mass index, mater-
nal race/ethnicity, maternal education, Home Observation for Measurement of the
Environment (HOME) score, duration of breastfeeding, maternal age, child age at test-
ing, and maternal marital status.
aStratify by sex.
bExposure by sex product term.
cExposure by sex product term and covariate by sex product terms for all covariates
(results published by Doherty et al. 2017).
dExposure by sex product term and covariate by sex product terms for the following
covariates: maternal race/ethnicity, maternal education, HOME score, duration of
breastfeeding, child age at testing, and maternal marital status.
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that stratification and the augmented product term approach yield
identical estimates that are less biased than the traditional product
term approach when there are sex-dependent confounders. This
finding has implications for studies in which sex-dependent
effects of EDs are of interest, and it specifically highlights that
the exposure by sex product term p-value from a traditional prod-
uct term model does not quantify the degree of EMM in estimates
produced using stratification. These are different models with dif-
ferent underlying assumptions.
The frequency of meaningful differences in interpretation
among these approaches is unknown. Investigators rarely report
estimates using more than one approach, and sex differences in
associations for many outcomes are not well characterized in the
literature. In our area of prenatal ED exposures and child devel-
opment, variables commonly considered to be confounders, such
as gestational stress and tobacco smoke exposure, have also been
reported to have sex-dependent associations with child health
outcomes (Barrett and Swan 2015; Chang et al. 2012; Fergusson
et al. 1998; Golding et al. 2014; Petkovsek et al. 2014; Riedel
et al. 2014). While more work is needed to determine how often
sex-dependent confounding occurs, we suspect that it may be
common in the ED literature and necessitates appropriate analysis
techniques.
Compared with either stratification or the augmented product
term approach, our simulations showed that the traditional prod-
uct term approach is susceptible to bias in the presence of con-
founders with sex-dependent effects on the outcome. However,
this approach had consistently smaller standard errors and outper-
formed other methods in terms of MSE in many of the scenarios
we explored. We recommend the use of stratification or aug-
mented product terms when bias is of primary concern or when
there is prior knowledge that confounders have sex-specific rela-
tionships with the outcome under study.
Beta coefficients estimated using the augmented product term
approach are equivalent to stratification when the analyst includes
product terms between the stratifying variable (i.e., sex) and all
other variables and interaction terms of interest. Standard errors
are also equivalent when the residual variation in the outcome is
similar among categories of the stratifying variable. As we have
discussed, a given analysis typically includes many confounders,
of which only a subset has sex-dependent associations with the
outcome. The reduced version of the augmented product term
approach offers a payoff in terms of variance reduction compared
to the stratified approach while maintaining improved validity
over the traditional product term approach. Indeed, this approach
performed well in our simulation when one confounder had sex-
dependent effects but the other did not. We recommend reduced
models be specified a priori by excluding product terms for vari-
ables with strong evidence indicating no sex differences based on
relationships reported in the literature. Alternatively, a data-
driven approach could be cautiously applied to avoid well-known
limitations of automated model reduction procedures (Greenland
1989). We suggest prespecifying product terms of interest using
prior knowledge and reporting details of any additional post hoc
analyses for model reduction. In general, the augmented product
term approach has advantages over stratification when there is a
priori knowledge available to fit reduced models or when investi-
gators seek an automated test for EMM of fully stratified
estimates.
In our applied example, absolute differences in beta coeffi-
cients were small, but we observed some meaningful differences
in conclusions between estimation approaches. In other studies,
the variability in estimated parameters between approaches will
depend on the degree of sexual heterogeneity of confounder asso-
ciations. The common practice of hypothesis testing based on a
specified a priori heterogeneity criterion (e.g., p-value<0:1) may
cause subtle modeling differences to alter conclusions for esti-
mates near the threshold, particularly in the setting of small sam-
ple sizes that characterize ED studies. In general, however, it is
more informative to report estimates of heterogeneity (such as
product term coefficients or alternative measures, such as the rel-
ative excess risk due to interaction) rather than results of hypoth-
esis tests (Greenland et al. 2008). We emphasize this point
because, as shown in our simulations, increased power to detect
modification can result either from a more sensitive hypothesis
test or from bias.
This work examined differences between analysis methods
under a relatively narrow range of simulated scenarios. We
selected parameters to illustrate our issue of concern using strong
sex-dependent associations of covariates with the outcome, and
we assessed the robustness of our findings to varying parameters
within our simple example. Although many more complex situa-
tions can be conceived, the qualitative results likely hold over a
range of parameter values. The relative utility of the various
approaches will depend on the question at hand. For example,
when two or more modifiers are of simultaneous interest, investi-
gators may choose to stratify into groups cross-classified by the
modifiers (e.g., White males, White females, Black males, Black
females), as the augmented product term approach may become
complex in this setting. Alternatively, an investigator could com-
bine approaches, stratifying by one variable and using augmented
product terms for the other. Rather than providing prescriptive
guidance on which method to use, we aimed to describe the per-
formance of available options in various situations so that investi-
gators may choose an optimal approach for their analysis.
Conclusions
Our findings suggest that variation in estimation approaches may
contribute to between-study heterogeneity in findings and that
establishing a consistent methodology is warranted to facilitate
comparisons. More generally, we recommend against the tradi-
tional product term approach when covariates may have sexually
heterogeneous associations with the outcome, as it can result in
biased estimates. Investigators interested in estimating sex-
specific effects of EDs should examine prior literature to under-
stand potential confounding due to sex differences in covariate–
outcome associations and apply appropriate methods to account
for such heterogeneity, such as stratification or the augmented
product term approach.
Acknowledgments
We thankM.Wolff for her leadership of theMount SinaiChildren’s
Environmental Health and Disease Prevention Research Center.
We thank Antonia Calafat, Manori Silva, Ella Samandar, and Jim
Preau for themeasurement of the phthalatemetabolites. B.T.D. and
A.P.K. were funded by a training grant from the National Institute
of Environmental Health Sciences (NIEHS, T32 ES007018).
J.P.B. and S.M.E. were supported by a grant from NIEHS
(5R01ES021777). The Mount Sinai Children’s Environmental
Health Study was supported by grants from NIEHS (ES009584),
U.S. EPA (R827039 and RD831711), ATSDR, and The NewYork
CommunityTrust.
References
Barrett ES, Swan SH. 2015. Stress and androgen activity during fetal development.
Endocrinology 156(10):3435–3441, PMID: 26241065, https://doi.org/10.1210/en.
2015-1335.
Bayley N. 1993. Bayley Scales of Infant Development, 2nd edition. San Antonio, TX:
Psychological Corporation.
Environmental Health Perspectives 067013-6
Braza P, Carreras R, Muñoz JM, Braza F, Azurmendi A, Pascual-Sagastizábal E,
et al. 2015. Negative maternal and paternal parenting styles as predictors of
children’s behavioral problems: Moderating effects of the child’s sex. J Child
Fam Stud 24(4):847–856, https://doi.org/10.1007/s10826-013-9893-0.
Caldwell BM, Bradley RH. 1979. HOME Observation for Measurement of the
Environment. Little Rock, AK:University of Arkansas Press.
Chang L, Cloak CC, Jiang CS, Hoo A, Hernandez AB, Ernst TM. 2012. Lower glial
metabolite levels in brains of young children with prenatal nicotine exposure. J
Neuroimmune Pharmacol 7(1):243–252, https://doi.org/10.1007/s11481-011-9311-6.
Colborn T, vom Saal FS, Soto AM. 1993. Developmental effects of endocrine-
disrupting chemicals in wildlife and humans. Environ Health Perspect 101
(5):378–384, PMID: 8080506.
Doherty BT, Engel SM, Buckley JP, Silva MJ, Calafat AM, Wolff MS. 2017. Prenatal
phthalate biomarker concentrations and performance on the Bayley Scales of
Infant Development-II in a population of young urban children. Environ Res
152:51–58, PMID: 27741448, https://doi.org/10.1016/j.envres.2016.09.021.
Engel SM, Berkowitz GS, Barr DB, Teitelbaum SL, Siskind J, Meisel SJ, et al. 2007.
Prenatal organophosphate metabolite and organochlorine levels and perform-
ance on the brazelton neonatal behavioral assessment scale in a multiethnic
pregnancy cohort. Am J Epidemiol 165(12):1397–1404, https://doi.org/10.1093/
aje/kwm029.
Fergusson DM, Woodward LJ, Horwood LJ. 1998. Maternal smoking during preg-
nancy and psychiatric adjustment in late adolescence. Arch Gen Psychiatry 55
(8):721–727, PMID: 9707383.
Golding J, Northstone K, Gregory S, Miller LL, Pembrey M. 2014. The anthropome-
try of children and adolescents may be influenced by the prenatal smoking
habits of their grandmothers: A longitudinal cohort study. Am J Hum Biol 26
(6):731–739, https://doi.org/10.1002/ajhb.22594.
Greenland S. 1989. Modeling and variable selection in epidemiologic analysis. Am
J Public Health 79(3):340–349, PMID: 2916724.
Greenland S, Lash T, Rothman K. 2008. Concepts of interaction. In: Modern
Epidemiology. 3rd Edition. PA:Lippincott Williams & Wilkins.
Ingleby FC, Flis I, Morrow EH. 2014. Sex-biased gene expression and sexual con-
flict throughout development. Cold Spring Harb Perspect Biol 7(1):1–17, PMID:
25376837, https://doi.org/10.1101/cshperspect.a017632.
Kato K, Silva MJ, Needham LL, Calafat AM. 2005. Determination of 16 phthalate
metabolites in urine using automated sample preparation and on-line precon-
centration/high-performance liquid chromatography/tandem mass spectrometry.
Anal Chem 77(9):2985–2991, PMID: 15859620, https://doi.org/10.1021/ac0481248.
Lenroot RK, Gogtay N, Greenstein DK, Wells EM, Wallace GL, Clasen LS, et al. 2007.
Sexual dimorphism of brain developmental trajectories during childhood and
adolescence. Neuroimage 36(4):1065–1073, PMID: 17513132, https://doi.org/10.
1016/j.neuroimage.2007.03.053.
Nugent BM, McCarthy MM. 2011. Epigenetic underpinnings of developmental sex
differences in the brain. Neuroendocrinology 93(3):150–158, PMID: 21411982,
https://doi.org/10.1159/000325264.
O'Brien KM, Upson K, Cook NR, Weinberg CR. 2016. Environmental chemicals
in urine and blood: Improving methods for creatinine and lipid adjust-
ment. Environ Health Perspect 124(2):220–227, https://doi.org/10.1289/ehp.
1509693.
Paternoster R, Brame R, Mazerolle P, Piquero A. 1998. Using the correct statistical
test for the equality of regression coefficients. Criminology 36(4):859–866,
https://doi.org/10.1111/j.1745-9125.1998.tb01268.x.
Petkovsek MA, Boutwell BB, Beaver KM, Barnes JC. 2014. Prenatal smoking and
genetic risk: Examining the childhood origins of externalizing behavioral
problems. Soc Sci Med 111:17–24, https://doi.org/10.1016/j.socscimed.2014.
03.028.
Riedel C, Fenske N, Müller MJ, Plachta-Danielzik S, Keil T, Grabenhenrich L, et al.
2014. Differences in BMI z-scores between offspring of smoking and nonsmok-
ing mothers: a longitudinal study of German children from birth through 14 years
of age. Environ Health Perspect 122(7):761–767, PMID: 24695368, https://doi.org/
10.1289/ehp.1307139.
Ronen D, Benvenisty N. 2014. Sex-dependent gene expression in human pluripo-
tent stem cells. Cell Rep 8(4):923–932, PMID: 25127145, https://doi.org/10.1016/j.
celrep.2014.07.013.
Tung I, Li JJ, Lee SS. 2012. Child sex moderates the association between negative
parenting and childhood conduct problems. Aggress Behav 38(3):239–251,
PMID: 22531998, https://doi.org/10.1002/ab.21423.
Vallotton CD, Harewood T, Ayoub CA, Pan B, Mastergeorge AM, Brophy-Herb H.
2012. Buffering boys and boosting girls: The protective and promotive effects
of Early Head Start for children's expressive language in the context of parent-
ing stress. Early Child Res Q 27(4):696–707, PMID: 23166405, https://doi.org/10.
1016/j.ecresq.2011.03.001.
VanderWeele TJ, Robins JM. 2010. Signed directed acyclic graphs for causal in-
ference. J R Stat Soc Series B Stat Methodol 72(1):111–127, PMID: 25419168,
https://doi.org/10.1111/j.1467-9868.2009.00728.x.
Weinberg CR. 2007. Can DAGs clarify effect modification?. Epidemiology 18(5):569–
572, PMID: 17700243, https://doi.org/10.1097/EDE.0b013e318126c11d.
Environmental Health Perspectives 067013-7
